Performance of the new 2022 ACR/EULAR classification criteria for giant cell arteritis in clinical practice in relation to its clinical phenotypes
Authors:
- 19 August 2023
- journal article
- research article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 22 (10) , 103413
Abstract
No abstract availableKeywords
Funding Information
- Fundación Española de Reumatología (FERBT2022)
This publication has 18 references indexed in Scilit:
- Symptomatic aortitis at giant cell arteritis diagnosis: a prognostic factor of aortic eventArthritis Research & Therapy, 2021
- Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesionsArthritis Research & Therapy, 2020
- 2018 Update of the EULAR recommendations for the management of large vessel vasculitisAnnals of the Rheumatic Diseases, 2020
- EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practiceAnnals of the Rheumatic Diseases, 2018
- FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNCEuropean Journal of Nuclear Medicine and Molecular Imaging, 2018
- Large-vessel giant cell arteritis: diagnosis, monitoring and managementRheumatology, 2018
- Prevalence of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumaticaSeminars in Arthritis and Rheumatism, 2015
- Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosisAnnals of the Rheumatic Diseases, 2013
- Aortic and extracranial large vessel giant cell arteritis: A review of 72 cases with histopathologic documentationSeminars in Arthritis and Rheumatism, 1995
- The American College of Rheumatology 1990 criteria for the classification of giant cell arteritisArthritis & Rheumatism, 1990